Octapharma Biopharmaceuticals GmbH

Since the founding of Octapharma Biopharmaceuticals GmbH in 1997, our experience in the area of research and development in the field of human cell lines has evolved extensively, resulting in the maturation of an effective, product-oriented biotechnology firm.
Our core competence is the development of recombinant pharmaceuticals as a modern alternative to plasma products.
Octapharma Biopharmaceuticals GmbH is a subsidiary company of the Octapharma AG. With approximately 6500 employees Octapharma is one of the largest human protein products manufacturers in the world and has been committed to patient care and medical innovation for 30 years.